3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
8
Sarcoma
7
Sarcoma, Clear Cell
2
Neurofibrosarcoma
2
Nerve Sheath Neoplasms
2
Neoplasm Metastasis
2
Liposarcoma
2
Kidney Neoplasms
2
Histiocytoma, Angiomatoid Fibrous
2
Granuloma, Plasma Cell
2
Glioblastoma
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Solid Neoplasm
1
Smooth Muscle Tumor
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Refractory or Recurrent Solid Tumor
1
Perivascular Epithelioid Cell Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Liposarcoma, Myxoid
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Interventions
Specimen Handling
9
Magnetic Resonance Spectroscopy
6
Biopsy
6
pembrolizumab
3
X-Rays
3
Nivolumab
3
olaparib
2
durvalumab
2
ceralasertib
2
Paclitaxel
2
Immunoglobulin G
2
Carboplatin
2
trastuzumab deruxtecan
1
sargramostim
1
ribociclib
1
pelcitoclax
1
cobimetinib
1
cediranib
1
capivasertib
1
cabozantinib
1
atezolizumab
1
Tissue Banks
1
Taxes
1
TIC10 compound
1
Radiation
1
Phantoms, Imaging
1
Minimally Invasive Surgical Procedures
1
Ipilimumab
1
Indocyanine Green
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
pazopanib
×
1 year
×
Clear all
No trials found.